We are live on ! Find out more
TS

Third Security Portfolio holdings

AUM $241M Turnover 0%
1-Year Est. Return 45.43%
This Fund
S&P 500
This Quarter Est. Return
-5.07%
1 Year Est. Return
-45.43%
3 Year Est. Return
-28.24%
5 Year Est. Return
-58.7%
10 Year Est. Return
–
AUM
$670M
AUM Growth
-$63.1M
Cap. Flow
-$7.91M
Cap. Flow %
-1.18%
Top 10 Hldgs %
99.92%
Holding
15
New
–
Increased
1
Reduced
–
Closed
3
Avg Time Held
4.5 years
Top 10 Avg Time Held
2.9 years
Top 20 Avg Time Held
4.5 years

Top Buys

Rank Stock Value
1
PGEN icon
Precigen
PGEN
+$714K

Top Sells

Rank Stock Value
1
TCRT icon
Alaunos Therapeutics
TCRT
+$8.16M
2
OCGN icon
Ocugen
OCGN
+$238K
3
EBS icon
Emergent Biosolutions
EBS
+$226K

Sector Composition

Rank Sector Weight
1 Healthcare 88.48%
2 Energy 8.52%
3 Consumer Staples 2.97%
4 Materials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PGEN icon
1
Precigen
PGEN
$2.38B
$357M 53.2%
67,791,169
+102,999
+0.2% +$714K
2013 Q3
22 quarters
HALO icon
2
Halozyme
HALO
$13.9B
$227M 33.85%
14,092,771
– –
2013 Q2
23 quarters
EPD icon
3
Enterprise Products Partners
EPD
$79.5B
$33M 4.93%
1,135,734
– –
2013 Q2
23 quarters
AQB icon
4
AquaBounty Technologies
AQB
$5.35M
$19.9M 2.97%
453,838
– –
2017 Q1
8 quarters
ET icon
5
Energy Transfer Partners
ET
$69.2B
$16.5M 2.46%
1,073,990
– –
2013 Q2
23 quarters
PTCT icon
6
PTC Therapeutics
PTCT
$5.14B
$5.18M 0.77%
137,551
– –
2018 Q3
2 quarters
NS icon
7
DELISTED
NuStar Energy L.P.
NS
$3.9M 0.58%
145,200
– –
2013 Q2
23 quarters
TCP
8
DELISTED
TC Pipelines LP
TCP
$3.62M 0.54%
97,000
– –
2013 Q2
23 quarters
FCSC
9
DELISTED
Fibrocell Science Inc.
FCSC
$3.19M 0.48%
1,653,486
– –
2013 Q2
23 quarters
OGEN icon
10
Oragenics
OGEN
$1.9M
$906K 0.14%
860
– –
2013 Q2
23 quarters
KWR icon
11
Quaker Houghton
KWR
$2.69B
$258K 0.04%
1,290
– –
2018 Q3
2 quarters
TOVX icon
12
Theriva Biologics
TOVX
$9.39M
$256K 0.04%
1,513
– –
2013 Q2
23 quarters
EBS icon
13
Emergent Biosolutions
EBS
$326M
– –
-3,810
Closed -$226K –
OCGN icon
14
Ocugen
OCGN
$267M
– –
-44,843
Closed -$238K –
TCRT icon
15
Alaunos Therapeutics
TCRT
$7.95M
– –
-29,094
Closed -$8.16M –

Similar funds

KRC
Kehrs Ridge Capital Holmdel, New Jersey $260M AUM 0.46% 1-Year Est. Return
A
Apoletto Road Town, Tortola, British Virgin Islands $260M AUM 31.4% 1-Year Est. Return
AIA
AGF Investments America Toronto, Ontario, Canada $271M AUM 7.04% 1-Year Est. Return
FG
Foundry Group Boulder, Colorado $209M AUM 47.6% 1-Year Est. Return
RFA
Radnor Financial Advisors Wayne, Pennsylvania $284M AUM 23.21% 1-Year Est. Return
UIA
UBP Investment Advisors Geneva, Switzerland $194M AUM 12.96% 1-Year Est. Return
GCM
Gabalex Capital Management New York $181M AUM 9.55% 1-Year Est. Return
GMA
Goldstein Munger & Associates San Ramon, California $303M AUM 19.66% 1-Year Est. Return

Third Security's Q1 2019 Portfolio in Review

As of Q1 2019, Third Security held 15 positions worth $670M, down 8.6% from $733M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Third Security's Q1 2019 filing shows 1 increased and 3 closed positions. The largest sale was Alaunos Therapeutics, an estimated $8.16M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 91% a quarter earlier, followed by Energy and Consumer Staples.

  • Third Security added most to Precigen in Q1 2019, an estimated $714K increase.
  • Third Security fully exited Alaunos Therapeutics in Q1 2019, selling an estimated $8.16M.
  • Third Security's ten largest holdings make up 100% of its $670M portfolio in Q1 2019.
  • Third Security opened 0 new positions and closed 3 in Q1 2019.
  • Third Security's portfolio value fell 8.6% quarter-over-quarter to $670M.

Based on Third Security's 13F filing for Q1 2019, filed 6 May 2019.